Eagle Bay Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,863
Closed -$27.8K 697
2024
Q4
$27.8K Sell
1,863
-637
-25% -$10.4K 0.02% 418
2024
Q3
$47.8K Sell
2,500
-300
-11% -$6.22K 0.02% 458
2024
Q2
$58K Hold
2,800
0.04% 315
2024
Q1
$52.6K Hold
2,800
0.03% 300
2023
Q4
$40.4K Buy
2,800
+1,400
+100% +$19K 0.03% 324
2023
Q3
$24.3K Hold
1,400
0.01% 502
2023
Q2
$29.1K Sell
1,400
-4
-0.3% -$87 0.02% 476
2023
Q1
$33K Sell
1,404
-600
-30% -$16.1K 0.02% 464
2022
Q4
$56K Buy
2,004
+290
+17% +$7.42K 0.03% 352
2022
Q3
$40K Buy
1,714
+235
+16% +$7.09K 0.02% 388
2022
Q2
$49.9K Buy
+1,479
New +$51.8K 0.03% 364
2022
Q1
Sell
-1,126
Closed -$35K 747
2021
Q4
$35K Sell
1,126
-491
-30% -$16K 0.02% 461
2021
Q3
$53K Buy
1,617
+1,065
+193% +$34.1K 0.03% 396
2021
Q2
$21K Buy
+552
New +$18.2K 0.02% 537

Other funds holding OGN

Eagle Bay Advisors's OGN Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 1,863 shares — an estimated $27.8K sold.

Eagle Bay Advisors first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $58K in Q2 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 1,863 Organon & Co shares in Q1 2025, an estimated $27.8K.
  • Eagle Bay Advisors first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
  • Eagle Bay Advisors's Organon & Co position peaked at $58K in Q2 2024.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.